Patents by Inventor Viktoria REINMÜLLER

Viktoria REINMÜLLER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL AROMATIC COMPOUNDS
    Publication number: 20230406814
    Abstract: The present invention comprises novel aromatic molecules, which can be used in the treatment of pathological conditions, such as cancer, skin diseases, muscle disorders, and immune system-related disorders such as disorders of the hematopoietic system including the hematologic system in human and veterinary medicine.
    Type: Application
    Filed: December 12, 2022
    Publication date: December 21, 2023
    Applicant: XENIOPRO GMBH
    Inventor: Viktoria REINMÜLLER
  • NOVEL AROMATIC COMPOUNDS
    Publication number: 20230150923
    Abstract: The present invention comprises novel aromatic molecules, which can be used in the treatment of pathological conditions, such as cancer, skin diseases, muscle disorders, and immune system-related disorders such as disorders of the hematopoietic system including the hematologic system in human and veterinary medicine.
    Type: Application
    Filed: December 12, 2022
    Publication date: May 18, 2023
    Applicant: XENIOPRO GMBH
    Inventor: Viktoria REINMÜLLER
  • PHENOXY(HETERO)ARYL ETHERS OF ANTIPROLIFERACTIVE ACTIVITY
    Publication number: 20230141913
    Abstract: The present invention comprises novel aromatic molecules, which can be used in the treatment of pathological conditions, such as cancer, skin diseases, muscle disorders, and immune system-related disorders such as disorders of the haematopoietic system including the haematologic system in human and veterinary medicine.
    Type: Application
    Filed: August 23, 2019
    Publication date: May 11, 2023
    Applicant: XENIOPRO GmbH
    Inventors: Viktoria REINMÜLLER, Roman MARTY, Olivier WAGNIÉRES, Jean-Baptiste GUALTIEROTTI, Verena KÜPPERS
  • Aromatic compounds
    Patent number: 11591289
    Abstract: The present invention comprises novel aromatic molecules, which can be used in the treatment of pathological conditions, such as cancer, skin diseases, muscle disorders, and immune system-related disorders such as disorders of the hematopoietic system including the hematologic system in human and veterinary medicine.
    Type: Grant
    Filed: February 26, 2018
    Date of Patent: February 28, 2023
    Assignee: Xeniopro GmbH
    Inventor: Viktoria Reinmüller
  • NOVEL COMPOUNDS
    Publication number: 20220354949
    Abstract: The present invention comprises novel aromatic molecules, which can be used in the treatment of pathological conditions, such as cancer, skin diseases, muscle disorders, and immune system-related disorders such as disorders of the haematopoietic system including the haematologic system in human and veterinary medicine.
    Type: Application
    Filed: August 23, 2019
    Publication date: November 10, 2022
    Applicant: XENIOPRO GmbH
    Inventors: Viktoria REINMÜLLER, Roman MARTY, Olivier WAGNIÈRES, Jean-Baptiste GUALTIEROTTI, Verena KÜPPERS
  • NOVEL AROMATIC COMPOUNDS
    Publication number: 20220348535
    Abstract: The present invention comprises novel aromatic molecules, which can be used in the treatment of pathological conditions, such as cancer, skin diseases, muscle disorders, and immune system-related disorders such as disorders of the hematopoietic system including the hematologic system in human and veterinary medicine.
    Type: Application
    Filed: February 26, 2018
    Publication date: November 3, 2022
    Applicant: XENIOPRO GMBH
    Inventor: Viktoria REINMÜLLER
  • PHENOXY(HETERO)ARYL ETHERS OF ANTIPROLIFERACTIVE ACTIVITY
    Publication number: 20220249500
    Abstract: The present invention comprises novel aromatic molecules, which can be used in the treatment of pathological conditions, such as cancer, skin diseases, muscle disorders, and immune system-related disorders such as disorders of the haematopoietic system including the haematologic system in human and veterinary medicine.
    Type: Application
    Filed: August 23, 2019
    Publication date: August 11, 2022
    Applicant: XENIOPRO GmbH
    Inventors: Viktoria REINMÜLLER, Roman MARTY, Olivier WAGNIÈRES, Jean-Baptiste GUALTIEROTTI, Verena KÜPPERS
  • METHOD FOR IDENTIFYING MODULATORS OF NOTCH SIGNALING
    Publication number: 20210382038
    Abstract: The present invention relates to use of inhibitors of Notch signalling pathway selected from the group consisting of 6-(4-Tert-Butylphenoxy)Pyridin-3-Amine (I3), its derivatives, in treating and/or preventing cancers.
    Type: Application
    Filed: June 22, 2021
    Publication date: December 9, 2021
    Inventors: Freddy RADTKE, Rajwinder LEHAL, Viktoria REINMÜLLER, Jieping ZHU
  • Method for identifying modulators of notch signaling
    Patent number: 11085918
    Abstract: The present invention relates to use of inhibitors of Notch signalling pathway selected from the group consisting of 6-(4-Tert-Butylphenoxy)Pyridin-3-Amine (I3), its derivatives, in treating and/or preventing cancers.
    Type: Grant
    Filed: March 25, 2019
    Date of Patent: August 10, 2021
    Assignee: ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL)
    Inventors: Freddy Radtke, Rajwinder Lehal, Viktoria Reinmüller, Jieping Zhu
  • NOVEL AROMATIC COMPOUNDS
    Publication number: 20210107863
    Abstract: The present invention comprises novel aromatic molecules, which can be used in the treatment of pathological conditions, such as cancer, skin diseases, muscle disorders, and immune system-related disorders such as disorders of the hematopoietic system including the hematologic system in human and veterinary medicine.
    Type: Application
    Filed: February 26, 2018
    Publication date: April 15, 2021
    Applicant: XENIOPRO GMBH
    Inventor: Viktoria REINMÜLLER
  • ENHANCERS OF NOTCH SIGNALING AND THEIR USE THEREOF IN THE TREATMENT OF CANCERS AND MALIGNANCIES MEDICABLE BY UPREGULATION OF NOTCH
    Publication number: 20200360355
    Abstract: The present invention relates to the use for enhancing Notch signaling in an individual, of a compound showing the general formula (I) and/or a pharmaceutically acceptable salt or ester thereof, for the treatment of a disease selected from the group of dermatological disorders including atopic dermatitis, psoriasis, immune related disorders, cancer, squamous cell carcinoma, cutaneous and lung squamous cell carcinoma, head and neck cancer, non-melanoma skin cancer, basal cell carcinoma and actinic keratosis, neuroendocrine tumors, neuroendocrine small cell carcinoma and carcinoid tumors, thyroid carcinomas, muscular disorders muscular dystrophy and impaired regeneration capacity after injury; use in immunotherapy for cancer.
    Type: Application
    Filed: July 24, 2020
    Publication date: November 19, 2020
    Applicant: XENIOPRO GmbH
    Inventors: Viktoria REINMUELLER, Jieping ZHU
  • Enhancers of Notch signaling and the use thereof in the treatment of cancers and malignancies medicable by upregulation of Notch
    Patent number: 10772876
    Abstract: The present invention relates to the use for enhancing Notch signaling in an individual, of a compound showing the general formula (I) and/or a pharmaceutically acceptable salt or ester thereof, for the treatment of a disease selected from the group of dermatological disorders including atopic dermatitis, psoriasis, immune related disorders, cancer, squamous cell carcinoma, cutaneous and lung squamous cell carcinoma, head and neck cancer, non-melanoma skin cancer, basal cell carcinoma and actinic keratosis, neuroendocrine tumors, neuroendocrine small cell carcinoma and carcinoid tumors, thyroid carcinomas, muscular disorders muscular dystrophy and impaired regeneration capacity after injury; use in immunotherapy for cancer.
    Type: Grant
    Filed: March 17, 2017
    Date of Patent: September 15, 2020
    Assignee: Xeniopro GmbH
    Inventors: Viktoria Reinmueller, Jieping Zhu
  • NOVEL AROMATIC COMPOUNDS
    Publication number: 20200031763
    Abstract: The present invention comprises novel aromatic molecules, which can be used in the treatment of pathological conditions, such as cancer, skin diseases, muscle disorders, and immune system-related disorders such as disorders of the hematopoietic system including the hematologic system in human and veterinary medicine.
    Type: Application
    Filed: February 26, 2018
    Publication date: January 30, 2020
    Applicant: XENIOPRO GMBH
    Inventor: Viktoria REINMÜLLER
  • METHOD FOR IDENTIFYING MODULATORS OF NOTCH SIGNALING
    Publication number: 20190219566
    Abstract: The present invention relates to use of inhibitors of Notch signalling pathway selected from the group consisting of 6-(4-Tert-Butylphenoxy)Pyridin-3-Amine (I3), its derivatives, in treating and/or preventing cancers.
    Type: Application
    Filed: March 25, 2019
    Publication date: July 18, 2019
    Applicant: ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL)
    Inventors: Freddy RADTKE, Rajwinder LEHAL, Viktoria REINMÜLLER, Jieping ZHU
  • Method for identifying modulators of notch signaling
    Patent number: 10274481
    Abstract: The present invention relates to use of inhibitors of Notch signalling pathway selected from the group consisting of 6-(4-Tert-Butylphenoxy)Pyridin-3-Amine (I3), its derivatives, in treating and/or preventing cancers.
    Type: Grant
    Filed: February 8, 2016
    Date of Patent: April 30, 2019
    Assignee: ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL)
    Inventors: Freddy Radtke, Rajwinder Lehal, Viktoria Reinmüller, Jieping Zhu
  • ENHANCERS OF NOTCH SIGNALING AND THE USE THEREOF IN THE TREATMENT OF CANCERS AND MALIGNANCIES MEDICABLE BY UPREGULATION OF NOTCH
    Publication number: 20190083476
    Abstract: The present invention relates to the use for enhancing Notch signaling in an individual, of a compound showing the general formula (I) and/or a pharmaceutically acceptable salt or ester thereof, for the treatment of a disease selected from the group of dermatological disorders including atopic dermatitis, psoriasis, immune related disorders, cancer, squamous cell carcinoma, cutaneous and lung squamous cell carcinoma, head and neck cancer, non-melanoma skin cancer, basal cell carcinoma and actinic keratosis, neuroendocrine tumors, neuroendocrine small cell carcinoma and carcinoid tumors, thyroid carcinomas, muscular disorders muscular dystrophy and impaired regeneration capacity after injury; use in immunotherapy for cancer.
    Type: Application
    Filed: March 17, 2017
    Publication date: March 21, 2019
    Applicant: XENIOPRO GmbH
    Inventors: Viktoria REINMUELLER, Jieping ZHU
  • Inhibitors of notch signaling pathway and use thereof in treatment of cancers
    Patent number: 10054581
    Abstract: The present invention relates to use of inhibitors of Notch signalling pathway selected from the group consisting of 6-(4-Tert-Butylphenoxy)Pyridin-3-Amine (I3), its derivatives, in treating and/or preventing cancers.
    Type: Grant
    Filed: March 14, 2018
    Date of Patent: August 21, 2018
    Assignee: Ecole Polytechnique Federale de Lausanne (EPFL)
    Inventors: Freddy Radtke, Rajwinder Lehal, Viktoria Reinmüller, Jieping Zhu
  • INHIBITORS OF NOTCH SIGNALLING PATHWAY AND USE THEREOF IN TREATMENT OF CANCERS
    Publication number: 20180224429
    Abstract: The present invention relates to use of inhibitors of Notch signalling pathway selected from the group consisting of 6-(4-Tert-Butylphenoxy)Pyridin-3-Amine (I3), its derivatives, in treating and/or preventing cancers.
    Type: Application
    Filed: March 14, 2018
    Publication date: August 9, 2018
    Inventors: Freddy RADTKE, Rajwinder LEHAL, Viktoria REINMÜLLER, Jieping ZHU
  • INHIBITORS OF NOTCH SIGNALLING PATHWAY AND USE THEREOF IN TREATMENT OF CANCERS
    Publication number: 20160266095
    Abstract: The present invention relates to use of inhibitors of Notch signalling pathway selected from the group consisting of 6-(4-Tert-Butylphenoxy)Pyridin-3-Amine (I3), its derivatives, in treating and/or preventing cancers.
    Type: Application
    Filed: February 8, 2016
    Publication date: September 15, 2016
    Inventors: Freddy RADTKE, Rajwinder LEHAL, Viktoria REINMÜLLER, Jieping ZHU